Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026
Myriad Genetics will release its second quarter 2026 financial results on July 30, 2026, followed by a conference call featuring management's overview and business update. The company specializes in molecular diagnostic testing and precision medicine.